Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Antibiotics (Basel, Switzerland)|March 27, 2024
Relationship between Target Time above Minimum Inhibitory Concentration Achievement Rate of Meropenem Using Monte Carlo Simulation and In-Hospital Survival in Patients with <i>Pseudomonas aeruginosa</i> BacteremiaHajime Nakashima, Motoyasu Miyazaki, Tsuneo Kuwamura, et al.
BMC Infectious Diseases|June 9, 2026
Effect of adding metronidazole to meropenem on clinical efficacy in complicated intra-abdominal infections: a retrospective studyHajime Nakashima, Motoyasu Miyazaki, Naoaki Nishimura, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2024
Adult severe community-acquired pneumonia with bloodstream infection caused by ψUSA 300: A case reportShinichi Morimoto, Mituhiro Kamada, Yuka Motomura, et al.
Journal of Clinical Medicine|December 23, 2023
Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational StudyKou Masaki, Motoyasu Miyazaki, Hideki Kakimoto, et al.
Biological & Pharmaceutical Bulletin|April 4, 2014
Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese centerMotoyasu Miyazaki, Nobuhiko Nagata, Hiroyuki Miyazaki, et al.
Journal of Pharmaceutical Health Care and Sciences|October 18, 2024
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitisArisa Fukuyama, Akio Nakashima, Motoyasu Miyazaki, et al.
Cancer Diagnosis & Prognosis|November 6, 2024
Factors Associated With Infusion Reactions in Patients With Breast Cancer Receiving TrastuzumabRyuji Yamaguchi, Masanobu Uchiyama, Motoyasu Miyazaki, et al.
Journal of Clinical Medicine Research|February 1, 2019
Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient EnrollmentKeisuke Okamura, Kazuyuki Shirai, Motoyasu Miyazaki, et al.
Microorganisms|October 14, 2020
The Effects of Silver Sulfadiazine on Methicillin-Resistant <i>Staphylococcus aureus</i> BiofilmsYutaka Ueda, Motoyasu Miyazaki, Kota Mashima, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with <i>Clostridioides difficile</i> InfectionYota Yamada, Motoyasu Miyazaki, Hisako Kushima, et al.
Pageof 5